Insider Transactions in Q1 2024 at Lumos Pharma, Inc. (LUMO)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 06
2024
|
John C. Mc Kew Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
438
-2.32%
|
$1,314
$3.03 P/Share
|
|
Feb 01
2024
|
John C. Mc Kew Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
366
-1.91%
|
$1,098
$3.01 P/Share
|
|
Feb 01
2024
|
Bradley J Powers General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
240
-4.01%
|
$720
$3.01 P/Share
|
|
Feb 01
2024
|
Aaron Schuchart Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
202
-3.43%
|
$606
$3.01 P/Share
|
|
Feb 01
2024
|
Lori D Lawley Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
215
-1.79%
|
$645
$3.01 P/Share
|
|
Feb 01
2024
|
Richard J Hawkins Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
690
-0.09%
|
$2,070
$3.01 P/Share
|